academic article

• Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury..  The Clinical journal of pain.  34:168-177. 2018
• Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model..  Molecular pain.  14:-. 2018
• PPARγ Agonists Attenuate Trigeminal Neuropathic Pain..  The Clinical journal of pain.  33:1071-1080. 2017
• Improved safety and efficacy of (213)Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysine. 2016
• Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice..  Journal of oral & facial pain and headache.  30:42-50. 2016
• Persistent neuropathic pain influences persistence behavior in rats..  Journal of oral & facial pain and headache.  29:183-192. 2015
• Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents..  ACS chemical biology.  5:681-690. 2010
• Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation..  Nuclear medicine and biology.  35:673-678. 2008
• Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells..  Nuclear medicine and biology.  34:185-193. 2007
• A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro..  Cancer biotherapy & radiopharmaceuticals.  20:52-57. 2005